PEPG insider transaction filings
PepGen Inc. — 41 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-22. Screen PEPG transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Wyman Lisa — Director | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Mayer Howard — Director | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Resnick Joshua — Director | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Dable Habib J — Director | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | KEATING LAURIE — Director | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Finer Mitchell H. — Director | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund II, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | HENSON HEIDI — Director | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Kasraian Kasra — Chief Technical Officer | Sale (S): 1,233 @ $1.41 | EDGAR |
| 2026-03-06 | 4 | Donnelly Noel — Chief Financial Officer | Sale (S): 2,032 @ $6.23 · Sale (S): 52 @ $6.33 | EDGAR |
| 2026-03-06 | 4 | McArthur James G — President and CEO, Director | Sale (S): 5,144 @ $6.23 · Sale (S): 131 @ $6.33 | EDGAR |
| 2026-03-06 | 4 | STRECK PAUL — EVP, Head of R&D | Sale (S): 1,832 @ $6.23 · Sale (S): 47 @ $6.29 | EDGAR |
| 2026-03-02 | 4 | Kasraian Kasra — Chief Technical Officer | Grant/award (A): 34,557 @ $0 · Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Donnelly Noel — Chief Financial Officer | Grant/award (A): 76,793 @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | McArthur James G — President and CEO, Director | Grant/award (A): 187,688 @ $0 · Grant/award (A): 731,250 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | STRECK PAUL — EVP, Head of R&D | Grant/award (A): 50,300 @ $0 · Grant/award (A): 196,500 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Vittiglio Joseph — Chief Business & Legal Officer | Grant/award (A): 30,717 @ $0 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Donnelly Noel — Chief Financial Officer | Disposition to issuer (D): 203,339 (derivative) @ $0 · Grant/award (A): 203,339 (derivative) @ $0 · Disposition to issuer (D): 169,037 (derivative) @ $0 · Grant/award (A): 169,037 (derivative) @ $0 · Disposition to issuer (D): 144,000 (derivative) @ $0 · Grant/award (A): 144,000 (derivative) @ $0 · +2 more | EDGAR |
| 2025-12-18 | 4 | McArthur James G — President and CEO, Director | Disposition to issuer (D): 352,705 (derivative) @ $0 · Grant/award (A): 352,705 (derivative) @ $0 · Disposition to issuer (D): 40,815 (derivative) @ $0 · Grant/award (A): 40,815 (derivative) @ $0 · Disposition to issuer (D): 40,815 (derivative) @ $0 · Grant/award (A): 40,815 (derivative) @ $0 · +8 more | EDGAR |
| 2025-12-18 | 4 | STRECK PAUL — EVP, Head of R&D | Disposition to issuer (D): 202,816 (derivative) @ $0 · Grant/award (A): 202,816 (derivative) @ $0 · Disposition to issuer (D): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Vittiglio Joseph — Chief Business & Legal Officer | Grant/award (A): 35,000 @ $0 · Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | Oxford Science Enterprises plc | Purchase (P): 200,000 @ $3.20 | EDGAR |
| 2025-09-30 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund II, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 9,375,000 @ $3.20 | EDGAR |
| 2025-06-06 | 4 | Mayer Howard — Director | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Resnick Joshua — Director | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Dable Habib J — Director | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | KEATING LAURIE — Director | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund II, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | HENSON HEIDI — Director | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | STRECK PAUL — EVP, Head of R&D | Purchase (P): 8,375 @ $1.24 | EDGAR |
| 2025-05-21 | 4 | Kasraian Kasra — Chief Technical Officer | Grant/award (A): 16,750 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-04-22 | 4 | McArthur James G — President and CEO, Director | Purchase (P): 10,000 @ $1.35 | EDGAR |
| 2025-04-09 | 4 | McArthur James G — President and CEO, Director | Purchase (P): 41,500 @ $1.15 | EDGAR |
| 2025-03-31 | 4 | Wyman Lisa — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | Finer Mitchell H. — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Donnelly Noel — Chief Financial Officer | Grant/award (A): 23,283 @ $0 · Grant/award (A): 104,250 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | McArthur James G — President and CEO, Director | Grant/award (A): 60,719 @ $0 · Grant/award (A): 271,875 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | STRECK PAUL — EVP, Head of R&D | Grant/award (A): 19,430 @ $0 · Grant/award (A): 87,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | DeLena Mary Beth — General Counsel | Grant/award (A): 13,400 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | Donnelly Noel — Chief Financial Officer | Grant/award (A): 3,200 @ $0 · Sale (S): 1,527 @ $1.68 | EDGAR |
| 2025-02-26 | 4 | DeLena Mary Beth — General Counsel | Grant/award (A): 3,000 @ $0 · Sale (S): 1,432 @ $1.68 | EDGAR |
Recent 8-K events — PepGen Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-21 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-04 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PEPG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →